Raleigh Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
LMFP
FWIA
DC
ETC
GI
MAA
WA
Raleigh Capital Management's MDT Position: Q2 2026 in Review
Raleigh Capital Management increased its Medtronic (MDT) stake by 122% in Q2 2026, buying an estimated $1.34M and bringing the position to 30,084 shares worth $2.35M. The position accounts for 0.75% of the portfolio, ranked #37.
Raleigh Capital Management first reported a position in MDT in Q4 2021 and has held it in 19 quarters since. 534 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Raleigh Capital Management held 30,084 shares of Medtronic worth $2.35M as of Q2 2026.
- Raleigh Capital Management bought 16,556 Medtronic shares in Q2 2026, an estimated $1.34M.
- Medtronic made up 0.75% of Raleigh Capital Management's portfolio in Q2 2026, its #37 holding.
- Raleigh Capital Management first reported a position in Medtronic in Q4 2021 and has held it in 19 quarters since.
- 534 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.